Search

Search Constraints

You searched for: Author/Creator Li, Chung-Pin

Search Results

1. A Phase II Study of Sequential Capecitabine Plus Oxaliplatin Followed by Docetaxel Plus Capecitabine in Patients With Unresectable Gastric Adenocarcinoma: The TCOG 3211 Clinical Trial. Issue 3 (January 2016)

2. A Phase II Study of Sequential Capecitabine Plus Oxaliplatin Followed by Docetaxel Plus Capecitabine in Patients With Unresectable Gastric Adenocarcinoma: The TCOG 3211 Clinical Trial. Issue 3 (January 2016)

3. A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study. (September 2022)

7. CanStem111P trial: a Phase III study of napabucasin plus nab-paclitaxel with gemcitabine. (13th February 2019)

8. Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinoma. (May 2022)

10. Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors. Issue 41 (October 2017)